RECRUITING

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Description

Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.

Conditions

Study Overview

Study Details

Study overview

Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.

A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects With Open Angle Glaucoma

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Condition
Glaucoma
Intervention / Treatment

-

Contacts and Locations

Glendale

Arizona Advanced Eye Research Institute, Glendale, Arizona, United States, 85306

Fayetteville

Vold Vision, Fayetteville, Arkansas, United States, 72704

Beverly Hills

Beverly Hills Institute of Ophthalmology, Beverly Hills, California, United States, 90210

Chico

Reeve Woods Eye Center, Chico, California, United States, 95926

Sacramento

Sacramento Eye Consultants, A Medical Corporation, Sacramento, California, United States, 95815

Grand Junction

Grand Junction Eye Care, Grand Junction, Colorado, United States, 81501

Fort Myers

Eye Associates of Fort Myers, Fort Myers, Florida, United States, 33901

Eagle

Intermountain Eye Center, Eagle, Idaho, United States, 83616

Peoria

Illinois Eye Center, Peoria, Illinois, United States, 61615

Rock Island

Virdi Eye Clinic, Rock Island, Illinois, United States, 61201

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males and females, 46 years of age or older
  • * A diagnosis of primary open-angle glaucoma, who are candidates for medical therapy, laser treatment, or glaucoma-filtering surgery
  • * Pseudophakic with prior uncomplicated cataract surgery
  • * Angle closure, congenital, or secondary glaucoma
  • * Diagnosed degenerative visual disorders
  • * Clinically significant intraocular inflammation or infection

Ages Eligible for Study

46 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

iSTAR Medical,

Richard Beckman, MD, STUDY_DIRECTOR, iSTAR Medical

Study Record Dates

2029-07